In Response.
作者信息
Ranucci Marco
机构信息
Department of Cardiothoracic and Vascular Anesthesia and Intensive Care Unit (ICU), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato, San Donato Milanese, Milan, Italy,
出版信息
Anesth Analg. 2020 Aug;131(2):e119-e120. doi: 10.1213/ANE.0000000000004950.
Abstract
摘要
相似文献
1
In Response.作为回应。
Anesth Analg. 2020 Aug;131(2):e119-e120. doi: 10.1213/ANE.0000000000004950.
2
Studies on the titration curves of fibrinogen and clotted fibrinogen.纤维蛋白原和凝固纤维蛋白原滴定曲线的研究。
Hung Acta Physiol. 1948;1(6):238-47.
3
The reducing properties of fibrinogen; the role of SH groups in the clotting of fibrinogen.纤维蛋白原的还原特性；巯基在纤维蛋白原凝血中的作用。
Hung Acta Physiol. 1948;1(6):197-210.
4
[THE TRANSFORMATION OF FIBRINOGEN INTO FIBRIN. I. ACTION OF THROMBIN ON FIBRINOGEN].[纤维蛋白原向纤维蛋白的转化。I. 凝血酶对纤维蛋白原的作用]
Nouv Rev Fr Hematol. 1965 Mar-Apr;5:309-15.
5
Role of the hypophysis in the plasma fibrinogen response to trauma.垂体在血浆纤维蛋白原对创伤反应中的作用。
S Afr J Med Sci. 1953 Sep;18(2):85.
6
Transformation of fibrinogen into fibrin. II. Changes in pH during clotting of fibrinogen.纤维蛋白原向纤维蛋白的转化。II. 纤维蛋白原凝血过程中的pH变化。
J Biol Chem. 1954 Aug;209(2):733-41.
7
A fibrinogen-thrombin clot useful in tissue culture.一种在组织培养中有用的纤维蛋白原 - 凝血酶凝块。
Arch Pathol (Chic). 1947 Sep;44(3):321.
8
A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II.一组患有先天性纤维蛋白原异常的波兰患者：纤维蛋白原γ链中的2种新突变，科斯琴纤维蛋白原和罗兹纤维蛋白原II 。
Pol Arch Intern Med. 2022 Aug 22;132(7-8). doi: 10.20452/pamw.16314. Epub 2022 Aug 16.
9
Transformation of fibrinogen into fibrin. III. Kinetics of the pH change associated with the clotting of fibrinogen.纤维蛋白原向纤维蛋白的转化。III. 与纤维蛋白原凝血相关的pH变化动力学
Biochim Biophys Acta. 1963 Apr 2;71:97-108. doi: 10.1016/0006-3002(63)90989-2.
10
[Fibrinogen fractions].[纤维蛋白原组分]
Ukr Biokhim Zh. 1963;35:104-12.
引用本文的文献
1
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.用于评估新型冠状病毒肺炎止血功能的粘弹性测试：一项系统评价
J Clin Med. 2021 Apr 16;10(8):1740. doi: 10.3390/jcm10081740.
本文引用的文献
1
Falsely Low Fibrinogen Levels in COVID-19 Patients on Direct Thrombin Inhibitors.接受直接凝血酶抑制剂治疗的COVID-19患者纤维蛋白原水平假性降低
Anesth Analg. 2020 Aug;131(2):e117-e119. doi: 10.1213/ANE.0000000000004949.
2
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
3
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
4
Trials and Tribulations of Viscoelastic-Based Determination of Fibrinogen Concentration.基于黏弹性的纤维蛋白原浓度测定的试验与磨难。
Anesth Analg. 2020 Mar;130(3):644-653. doi: 10.1213/ANE.0000000000004522.
5
Influences of argatroban on five fibrinogen assays.阿加曲班对五种纤维蛋白原检测方法的影响。
Int J Lab Hematol. 2017 Dec;39(6):641-644. doi: 10.1111/ijlh.12719. Epub 2017 Aug 2.
6
Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.比伐卢定与常规肝素抗凝在心脏手术后体外膜肺氧合中的应用比较。
Crit Care. 2011;15(6):R275. doi: 10.1186/cc10556. Epub 2011 Nov 20.
7
Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.
Anesthesiology. 2008 Jul;109(1):160-1. doi: 10.1097/ALN.0b013e31817885b7.
Zotero 插件